NP0331755 | (3S,5S,8R,9S,10S,12S,13S,14R,17R,20R)-12β-O-4-hydroxyphenylacetyltenacigenin A | | | C29H38O7
498.6160 Da 498.26175 Da | 1H NMR Spectrum (1D, 400, CD3OD, simulated) | 1H NMR Spectrum (1D, 400 MHz, CD3OD, experimental) | 13C NMR Spectrum (1D, 101 MHz, CD3OD, experimental) | [1H, 13C] NMR Spectrum (2D, 400 MHz, CD3OD, experimental) | 1H NMR Spectrum (1D, 400 MHz, CD3OD, experimental) | [1H, 13C] NMR Spectrum (2D, 400 MHz, CD3OD, experimental) | [1H, 1H] NMR Spectrum (2D, 400 MHz, CD3OD, experimental) | [1H, 1H] NMR Spectrum (2D, 400 MHz, CD3OD, experimental) | 13C NMR Spectrum (1D, 101 MHz, CD3OD, experimental) |
|
NP0331756 | (3S,8S,9S,10R,11S,12S,13S,14R,17S)-11α,12β-acetonide-17β-marsdenin | | | C24H36O6
420.5460 Da 420.25119 Da | 1H NMR Spectrum (1D, 400, C5D5deposition_typeN, simulated) | 1H NMR Spectrum (1D, 400 MHz, C5D5N, experimental) | [1H, 1H] NMR Spectrum (2D, 400 MHz, C5D5N, experimental) | 1H NMR Spectrum (1D, 400 MHz, C5D5N, experimental) | 13C NMR Spectrum (1D, 101 MHz, C5D5N, experimental) | [1H, 13C] NMR Spectrum (2D, 400 MHz, C5D5N, experimental) | 1H NMR Spectrum (1D, 400 MHz, C5D5N, experimental) | [1H, 13C] NMR Spectrum (2D, 400 MHz, C5D5N, experimental) | 1H NMR Spectrum (1D, 400 MHz, C5D5N, experimental) | [1H, 1H] NMR Spectrum (2D, 400 MHz, C5D5N, experimental) | 13C NMR Spectrum (1D, 101 MHz, C5D5N, experimental) |
|
NP0331757 | 12β-O-acetyltenacigenin D | | | C23H32O6
404.5030 Da 404.21989 Da | 1H NMR Spectrum (1D, 400, CD3OD, simulated) | 1H NMR Spectrum (1D, 400 MHz, CD3OD, experimental) | 13C NMR Spectrum (1D, 101 MHz, CD3OD, experimental) | [1H, 13C] NMR Spectrum (2D, 400 MHz, CD3OD, experimental) | [1H, 13C] NMR Spectrum (2D, 400 MHz, CD3OD, experimental) | [1H, 1H] NMR Spectrum (2D, 400 MHz, CD3OD, experimental) | [1H, 1H] NMR Spectrum (2D, 400 MHz, CD3OD, experimental) | 13C NMR Spectrum (1D, 101 MHz, CD3OD, experimental) |
|
NP0331758 | Penicopeptide A | | | C34H32N4O4
560.6540 Da 560.24236 Da | |
NP0331759 | Versicomide H | | | C19H23N3O3
341.4110 Da 341.17394 Da | 1H NMR Spectrum (1D, 500, CDCl3, simulated) | 13C NMR Spectrum (1D, 126 MHz, CDCl3, experimental) | 1H NMR Spectrum (1D, 500 MHz, CDCl3, experimental) | [1H, 1H] NMR Spectrum (2D, 500 MHz, CDCl3, experimental) | [1H, 1H] NMR Spectrum (2D, 500 MHz, CDCl3, experimental) | [1H, 13C] NMR Spectrum (2D, 500 MHz, CDCl3, experimental) | [1H, 13C] NMR Spectrum (2D, 500 MHz, CDCl3, experimental) |
|
NP0331760 | 7-methoxydehydrocyclopeptin | | | C18H16N2O3
308.3370 Da 308.11609 Da | |
NP0331761 | Aspergilpeptide A | | | C36H36N4O6
620.7060 Da 620.26348 Da | |
NP0331762 | Versicomide G | | | C19H25N3O4
359.4260 Da 359.18451 Da | 1H NMR Spectrum (1D, 500, C2D6OS, simulated) | 1H NMR Spectrum (1D, 500 MHz, C2D6OS, experimental) | [1H, 13C] NMR Spectrum (2D, 500 MHz, C2D6OS, experimental) | [1H, 13C] NMR Spectrum (2D, 500 MHz, C2D6OS, experimental) | 13C NMR Spectrum (1D, 126 MHz, C2D6OS, experimental) | [1H, 1H] NMR Spectrum (2D, 500 MHz, C2D6OS, experimental) | [1H, 1H] NMR Spectrum (2D, 500 MHz, C2D6OS, experimental) |
|
NP0331763 | 7-Hydroxycoumarin | | | C9H6O3
162.1440 Da 162.03169 Da | 1H NMR Spectrum (1D, 600 MHz, CD3OD, experimental) | 1H NMR Spectrum (1D, 600 MHz, CD3OD, experimental) | [1H, 13C] NMR Spectrum (2D, 400 MHz, C2D6OS, experimental) | 13C NMR Spectrum (1D, 101 MHz, CD3OD, experimental) | 13C NMR Spectrum (1D, 101 MHz, CDCl3, experimental) | 1H NMR Spectrum (1D, 400 MHz, CD3OD, experimental) | [1H, 13C] NMR Spectrum (2D, 400 MHz, CD3OD, experimental) | 1H NMR Spectrum (1D, 400 MHz, CD3OD, experimental) | [1H, 1H] NMR Spectrum (2D, 400 MHz, CDCl3, experimental) | 13C NMR Spectrum (1D, 101 MHz, C2D6OS, experimental) | 13C NMR Spectrum (1D, 101 MHz, C2D6OS, experimental) | 13C NMR Spectrum (1D, 101 MHz, CDCl3, experimental) | [1H, 1H] NMR Spectrum (2D, 400 MHz, CD3OD, experimental) |
|
NP0331764 | 2-Methyl-1,4-napthoquinone | | | C11H8O2
172.1800 Da 172.05243 Da | 1H NMR Spectrum (1D, 600 MHz, CD3OD, experimental) | 1H NMR Spectrum (1D, 600 MHz, CD3OD, experimental) | 1H NMR Spectrum (1D, 600 MHz, CD3OD, experimental) | 1H NMR Spectrum (1D, 600 MHz, CD3OD, experimental) |
|
NP0331765 | n-Octyl β-D-glucopyranoside | | | C14H28O6
292.3685 Da 292.18859 Da | |
NP0331766 | Lignoceric acid | | | C24H48O2
368.6367 Da 368.36543 Da | |
NP0331767 | p-hydroxybenzaldehyde | | | C7H6O2
122.1213 Da 122.03678 Da | |
NP0331768 | Fimbricalyxinlignan A | | | C18H18O6
330.3360 Da 330.11034 Da | |
NP0331769 | Fimbricalyxinlignan B | | | C16H16O5
288.2990 Da 288.09977 Da | |
NP0331770 | Isocampheren-9-ene-10-ethylone | | | C14H22O2
222.3280 Da 222.16198 Da | 1H NMR Spectrum (1D, 600, CD3OD, simulated) | 1H NMR Spectrum (1D, 600 MHz, CD3OD, experimental) | [1H, 13C] NMR Spectrum (2D, 600 MHz, CD3OD, experimental) | 13C NMR Spectrum (1D, 151 MHz, CD3OD, experimental) | [1H, 13C] NMR Spectrum (2D, 600 MHz, CD3OD, experimental) | [1H, 1H] NMR Spectrum (2D, 600 MHz, CD3OD, experimental) | [1H, 1H] NMR Spectrum (2D, 600 MHz, CD3OD, experimental) | 13C NMR Spectrum (1D, 151 MHz, CD3OD, experimental) |
|
NP0331771 | 10-methyl-isocampheren-10-ene-11-acid | | | C15H24O3
252.3540 Da 252.17254 Da | 1H NMR Spectrum (1D, 600, CD3OD, simulated) | 1H NMR Spectrum (1D, 600 MHz, CD3OD, experimental) | [1H, 13C] NMR Spectrum (2D, 600 MHz, CD3OD, experimental) | 13C NMR Spectrum (1D, 151 MHz, CD3OD, experimental) | [1H, 1H] NMR Spectrum (2D, 600 MHz, CD3OD, experimental) | [1H, 13C] NMR Spectrum (2D, 600 MHz, CD3OD, experimental) | [1H, 1H] NMR Spectrum (2D, 600 MHz, CD3OD, experimental) | 13C NMR Spectrum (1D, 101 MHz, CD3OD, experimental) |
|
NP0331772 | 10-hydroxy-isocampheren-11-ene | | | C15H26O2
238.3710 Da 238.19328 Da | |
NP0331773 | (6 S,7E)− 6-hydroxy-4,7-megastigmadien-3,9-dione (S(+)-dehydrovomifoliol) | | | C13H18O3
222.2840 Da 222.12559 Da | |
NP0331774 | Punicaone | | | C30H44O4
468.6780 Da 468.32396 Da | |
NP0331775 | 6-Benzylaminopurine | | | C12H11N5
225.2492 Da 225.10145 Da | |
NP0331776 | n-Decyl-beta-D-Glucopyranoside | | | C16H32O6
320.4260 Da 320.21989 Da | |
NP0331777 | N,N-Dimethylglycine | | | C4H9NO2
103.1198 Da 103.06333 Da | |
NP0331778 | pseudobulbiferamide C | | | C36H49N11O10S
827.9200 Da 827.33846 Da | 1H NMR Spectrum (1D, 700 MHz, C2D6OS, experimental) | [1H, 1H] NMR Spectrum (2D, 700 MHz, C2D6OS, experimental) | [1H, 1H] NMR Spectrum (2D, 700 MHz, C2D6OS, experimental) | [1H, 1H] NMR Spectrum (2D, 700 MHz, C2D6OS, experimental) | 13C NMR Spectrum (1D, 176 MHz, C2D6OS, experimental) | [1H, 13C] NMR Spectrum (2D, 700 MHz, C2D6OS, experimental) | [1H, 13C] NMR Spectrum (2D, 700 MHz, C2D6OS, experimental) | 13C NMR Spectrum (1D, 176 MHz, C2D6OS, experimental) | 1H NMR Spectrum (1D, 700 MHz, C2D6OS, experimental) | [1H, 1H] NMR Spectrum (2D, 700 MHz, C2D6OS, experimental) | [1H, 1H] NMR Spectrum (2D, 700 MHz, C2D6OS, experimental) | [1H, 1H] NMR Spectrum (2D, 700 MHz, C2D6OS, experimental) | 13C NMR Spectrum (1D, 176 MHz, C2D6OS, experimental) | [1H, 13C] NMR Spectrum (2D, 700 MHz, C2D6OS, experimental) | [1H, 13C] NMR Spectrum (2D, 700 MHz, C2D6OS, experimental) |
|
NP0331779 | pseudobulbiferamide A | | | C35H47N11O10S
813.8900 Da 813.32281 Da | 1H NMR Spectrum (1D, 700 MHz, C2D6OS, experimental) | [1H, 1H] NMR Spectrum (2D, 700 MHz, C2D6OS, experimental) | [1H, 1H] NMR Spectrum (2D, 700 MHz, C2D6OS, experimental) | 13C NMR Spectrum (1D, 176 MHz, C2D6OS, experimental) | [1H, 13C] NMR Spectrum (2D, 700 MHz, C2D6OS, experimental) | [1H, 1H] NMR Spectrum (2D, 700 MHz, C2D6OS, experimental) | [1H, 13C] NMR Spectrum (2D, 700 MHz, C2D6OS, experimental) | 13C NMR Spectrum (1D, 176 MHz, C2D6OS, experimental) | 1H NMR Spectrum (1D, 700 MHz, C2D6OS, experimental) | [1H, 1H] NMR Spectrum (2D, 700 MHz, C2D6OS, experimental) | [1H, 1H] NMR Spectrum (2D, 700 MHz, C2D6OS, experimental) | 13C NMR Spectrum (1D, 176 MHz, C2D6OS, experimental) | [1H, 13C] NMR Spectrum (2D, 700 MHz, C2D6OS, experimental) | [1H, 1H] NMR Spectrum (2D, 700 MHz, C2D6OS, experimental) | [1H, 13C] NMR Spectrum (2D, 700 MHz, C2D6OS, experimental) |
|